Generex Biotechnology Corporation
GNBT · OTC
7/31/2020 | 7/31/2019 | 7/31/2018 | 7/31/2017 | |
|---|---|---|---|---|
| Market Cap | $4 | $4 | $3 | $2 |
| - Cash | $0 | $0 | $1 | $3 |
| + Debt | $11 | $8 | $14 | $14 |
| Enterprise Value | $15 | $12 | $16 | $12 |
| Revenue | $3 | $6 | $1 | $0 |
| % Growth | -57.1% | 782.2% | – | – |
| Gross Profit | $2 | $2 | $1 | $0 |
| % Margin | 78.2% | 33.3% | 100% | – |
| EBITDA | -$26 | -$21,072 | $37 | -$69 |
| % Margin | -981.2% | -339,654.2% | 5,252.9% | – |
| Net Income | -$33 | -$9 | $36 | -$70 |
| % Margin | -1,252.7% | -150.6% | 5,166.6% | – |
| EPS Diluted | -0.46 | -0.14 | 14.02 | -2.41 |
| % Growth | -228.6% | -101% | 681.7% | – |
| Operating Cash Flow | -$6 | -$10 | -$2 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$6 | -$10 | -$2 | -$1 |